Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study-Reference-Cited by-同舟云学术

Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study

Published:2007-02-23 Issue:4 Volume:192 Page:479-487
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Eser Daniela,Schüle Cornelius,Baghai Thomas,Floesser Anette,Krebs-Brown Axel,Enunwa Michaela,de la Motte Stephan,Engel Rolf,Kucher Klaus,Rupprecht Rainer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-007-0738-7.pdf

Reference44 articles.

1. Abelson JL, Liberzon I (1999) Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology 21:485–494

2. Abelson JL, Liberzon I, Young EA, Khan S (2005) Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry 62:668–675

3. Ackenheil M, Stotz G, Dietz-Bauer R, Vossen A (1999) Mini International Neuropsychiatric Interview, German version 5.0.0

4. Akiyoshi J, Isogawa K, Tsutsumi T, Kasturagi S, Kohno K, Furuta M, Yamamoto Y, Yamada K, Fujii I (1997) Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia. Biol Psychiatry 42:151–154

5. Aluoja A, Shlik J, Vasar V, Kingisepp PH, Jagomagi K, Vasar E, Bradwejn J (1997) Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers. Psychiatry Res 66:59–67

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical challenges for testing novel anti-panic drugs in humans;Pharmacology Biochemistry and Behavior;2024-09

2. Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease;Frontiers in Neuroendocrinology;2024-04

3. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males;CNS Drugs;2023-11-29

4. Brain Mechanisms Underlying Panic Attack and Panic Disorder;Neuroscience Bulletin;2023-07-21

5. Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms;Psychoneuroendocrinology;2019-12